Department of Drug Administration find 11% drug poor quality in financial year 2076/77 Checking the Quality of Medicine.
In the sample test conducted by the Department of Drug Administration in the financial year 2076/77,11% of the medicines failed
In the sample test conducted by the Department of Drug Administration in the financial year 2076/77, 10.9 percent quality of the drug has been found to be poor.
The department tested 1,018 samples in the last fiscal year and found that 111 or 10.9 percent of the medicines were found to be in poor quality, according to the Ninth Annual Report of the Auditor General. In the report, the department has instructed to return the medicines that have failed in quality but have not received any definite information as to whether they have been returned or their production has been stopped.
99 Pharmacy Suspended, 78 closed
The report states that the Department of Drug Administration has monitored and inspected 3,351 wholesalers, 20,232 retailers and 197 indigenous industries and 3 out of 424 drug importers, 404 drug sellers and 87 indigenous industries registered so far this year.
Similarly, sample testing of 1,018 drugs, laboratory tests of 30 industries and monitoring of 23 foreign drug importing firms have been monitored. The monitoring has suspended 99 drug stores, closed 78 drug stores and filed cases against 25 of them.
It has also been suggested to conduct the monitoring work more effectively as the number of monitors is less than the number registered in the report.
The Drugs Act 2035 and Rules 2038 provide for the department to regulate through licensing, renewal and regular monitoring of drug stores, warning to improve the weaknesses observed through monitoring, suspension and prosecution. Similarly, Section 24 of the Drugs Act, 2035 provides for the examination of drug samples.
- 50 Interesting Medicine Information Every Pharmacist Need to Know
- Nimesulide (NIMS), Uses, Side Effect, Dose
- Department of Drug Administration-DDA
- Department of Drug Administration- DDA Important Information Regarding Recall of Medicine
- Amlodipine, Uses, Side Effects, Dosages
Pharma Info Nepal (Nabin’s Blog) is Popular Pharmacy information sharing online platform initiated by Nabin Bist since 2019. Thousands of Pharmacy professionals have trusted Pharma Info Nepal as a right blog to find the latest Pharma opportunities, information & resources for pharmacy updates in Nepal . If you have any complaints, information, or suggestions about the content published on Pharma Info Nepal/If you also like to write an article, please feel free to contact at firstname.lastname@example.org. Thanks for visiting us.
Nepal’s Leading Pharma Portal | Complete Pharma Updates